Marshall Wace North America’s Globus Medical GMED Stock Holding History

Marshall Wace North America’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-18,626	Closed	-$923K	–	1404
2020 Q3	$923K	Buy	+18,626	New	+$961K	0.01%	829
2019 Q3	–	Sell	-118,715	Closed	-$5.02M	–	1385
2019 Q2	$5.02M	Buy	118,715 +59,501	+100%	+$2.58M	0.03%	360
2019 Q1	$2.93M	Buy	59,214 +30,082	+103%	+$1.36M	0.02%	423
2018 Q4	$1.26M	Sell	29,132 -37,911	-57%	-$1.89M	0.01%	552
2018 Q3	$3.81M	Buy	67,043 +40,550	+153%	+$2.13M	0.03%	371
2018 Q2	$1.34M	Buy	+26,493	New	+$1.38M	0.01%	869
2017 Q2	–	Sell	-215,414	Closed	-$6.46M	–	1347
2017 Q1	$6.46M	Buy	+215,414	New	+$5.88M	0.05%	341
2013 Q4	–	Sell	-30,930	Closed	-$540K	–	749
2013 Q3	$540K	Sell	30,930 -39,317	-56%	-$680K	0.02%	433
2013 Q2	$1.18M	Buy	+70,247	New	+$1.08M	0.09%	215

Other funds holding GMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Marshall Wace North America's GMED Position: Q4 2020 in Review

Marshall Wace North America sold out of Globus Medical (GMED) in Q4 2020, closing a stake of 18,626 shares — an estimated $923K sold.

Marshall Wace North America first reported a position in GMED in Q2 2013 and held it in 9 quarters. The position peaked at $6.46M in Q1 2017. 348 funds tracked by Wall St. Rank hold GMED as of Q4 2020.

Marshall Wace North America reported no remaining Globus Medical position as of Q4 2020 after selling out during the quarter.
Marshall Wace North America sold 18,626 Globus Medical shares in Q4 2020, an estimated $923K.
Marshall Wace North America first reported a position in Globus Medical in Q2 2013 and held it in 9 quarters.
Marshall Wace North America's Globus Medical position peaked at $6.46M in Q1 2017.
348 funds tracked by Wall St. Rank held Globus Medical as of Q4 2020.

Based on Marshall Wace North America's 13F filing for Q4 2020, filed 16 Feb 2021.